Skip to main content

Holiday schedule

Our Patient Service Centers will be closed on Wednesday, December 25, 2024 in observance of Christmas and Wednesday, January 1, 2025 in observance of New Year's Day. Have a healthy, happy holiday.

Hide
Quest Diagnostics

Data licensing

DATA LICENSING

Quest Lab Data

Helping to accelerate your product’s journey to the marketplace, safely.
Speak to an expert
DL_Inset-Image_1.jpg

Supporting you at every step to accelerate your speed to market

Typically, 70% of clinical decisions are made with lab data.1 Aggregated test results are a vast data pool waiting to be leveraged. Data-driven insights backed by lab data could significantly impact strategic drug development decisions.

Lab data can help support key development milestones:

  • Identify druggable targets and monitor disease progression during the research and development (R&D) phase
  • Estimate market size and prioritize research efforts during the R&D phase
  • Identify ideal locations for clinical trial sites
  • Identify principal investigator candidates based on physician data and target study participant locations
  • Identify the ideal clinical trial cohort makeup to ensure complete and representative participation
  • Identify patients who may be eligible for a new drug or therapy based on specific diagnostic inclusion and exclusion criteria
  • Identify patients who may benefit from second- or third-line therapies
  • Determine which providers may benefit from additional education on the latest therapies and associated diagnostic testing requirements
  • Demonstrate the efficacy of products to healthcare providers and payers
  • Monitor the safety and efficacy of a drug or therapy after it has gained market approval
  • Support Health Economics and Outcomes Research (HEOR) programs and demonstrate economic value of products to healthcare providers and payers

Comprehensive datasets to support research, development, and commercialization

From routine testing to advanced genetic testing, our data covers nearly all therapeutic areas. With one of the most comprehensive test menus in the industry, our lab data represent a diverse selection of therapeutic areas and medical conditions including:

  • Allergy/asthma
  • Arthritis
  • Autoimmune diseases
  • Bleeding and thrombosis
  • Cancer, general
  • Cancer, GI
  • Cancer, leukemia and lymphoma
  • Cancer, lung
  • Cancer, skin
  • Cancer, thyroid
  • Cardiovascular
  • Celiac disease
  • Diabetes
  • Endocrinology
  • Gastroenterology
  • General health
  • Genetics
  • Hepatitis B
  • Hepatitis C
  • HIV
  • Infectious diseases
  • Irritable bowel syndrome
  • Neurology
  • Pediatrics
  • Prescription drug monitoring
  • Rheumatoid arthritis
  • Skin disease
  • Toxicology
  • Women’s health

Our advanced lab test methodologies include:

  • Complete blood count
  • Mass spectrometry
  • Genomics
  • Anatomic pathology
  • Microbiology
  • Cell analysis and imaging
  • Immunohistochemistry

Learn more about our tests

The biomarker advantage webinar

Optimizing the robust genetics data available from Quest Diagnostics to provide new insights into drug development and clinical trials

Watch now
DL_Inset-Image_2-resized.jpg

Customized or curated therapeutic area datasets

Gain unique insights by either customizing datasets based on your criteria and use cases set by your organization or by utilizing the power of our precision-crafted, therapeutic area datasets. Curated by our medical professionals, our therapeutic area datasets are designed to provide comprehensive real world data (RWD) at an indication level.

  • Comprehensive data related to a specific indication
  • Pricing advantage—Enterprise license pricing covers all your clinical and commercial use cases
  • Greater flexibility to generate additional insights with discrete genetic results

Oncology datasets

  • Breast cancer
  • Prostate cancer
  • Liver cancer
  • Non-small cell lung cancer (NSCLC)
  • Colorectal cancer
  • Ovarian cancer
  • Multiple myeloma
  • Renal cell carcinoma

Other therapeutic datasets

  • Crohn's disease
  • Rheumatoid arthritis
  • Ulcerative colitis

Quest patient and provider data can help optimize clinical trial planning

We know how important patient and provider data can be in identifying clinical trial sites, cohorts, and principal investigators. We go beyond lab data to provide unique insights that close key information gaps in clinical trial planning to help you accelerate your time-to-market.

Patient data

More than 313M unique patient encounters

 

Key demographics include: age, gender, race, ethnicity, and geography

 

Identify the best cohort for trial participation and the most feasible trial site location

Provider data

Serving more than 50% of US physicians and hospitals each year

 

Help identify principal investigator candidates for clinical trials

 

Leverage our extensive provider network to reach patients about your clinical trial opportunity

White paper: 5 Ways Lab Data Can Help Commercialize Your Therapy

Learn how charting a clear course for commercialization will help ensure a successful launch of your precision medicine. Choosing the right CDx partner will have you ready for market day 1. 
View the white paper
A 3D visualization of the drug development pipeline from research to market

White paper: 6 Ways Lab Data Can Improve Clinical Trials

Discover how Quest Diagnostics’ comprehensive lab data can elevate your clinical trials. Our latest white paper, "6 Ways Lab Data Can Improve Clinical Trials," explores the power of real-world data at every stage of the trial process.
View the white paper
Healthcare professional using futuristic medical software for patient data analysis with an interactive virtual interface in a modern clinic

Case study: Data-driven physician engagement for ultra-rare diseases

Learn how Quest Diagnostics leveraged data analytics to help identify treating physicians of eligible patients for a new therapy targeting an ultra-rare and aggressive form of cancer.
Read the case study
Quest lab stewardship services working on reducing care variation through lab analytics

White paper: 6 key ways real-world data is accelerating breast cancer therapies

Learn how real-world data is driving breast cancer research forward, offering actionable strategies for advancing therapy development.
View the white paper
The innovative medical approach of immunotherapy, harnessing the body's immune system to fight diseases like cancer more effectively. Abstract concept. Generative AI

White paper: 8 Applications of Real-World Data in Multiple Myeloma Therapy Development

Explore how real-world data is driving innovation in multiple myeloma research. Our white paper reveals 8 key applications of RWD, from improving clinical trials to advancing biomarker discovery. 
View the white paper
Gene therapy targeting cancer cells Modern research lab, ai generative

The power of Quest

Quest Lab Data features include:

  • Access to a unique repository of real-world data
  • Deidentified near real-time data that is discretized and easy to analyze and adapt
  • Data can be merged with other deidentified data from data providers including: Datavant, HealthVerity, Komodo Health, Symphony Health, Management Science Associates, Prognos, and more

Let’s discuss your project

Contact our pharma solutions experts to design a custom program to accommodate the needs of your project.

Let's talk

References

  1. CDC. Strengthening clinical laboratories. November 15, 2018. Accessed April 24, 2024. https://www.cdc.gov/csels/dls/strengthening-clinical-labs.html

Let's discuss your project

Contact our pharma solutions experts to design a custom program to accommodate the needs of your project.

Let's talk

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.